Breaking News Instant updates and real-time market news.

SAGE

Sage Therapeutics

$91.90

2.11 (2.35%)

14:43
12/07/17
12/07
14:43
12/07/17
14:43

Sage Therapeutics price target raised to $203 from $112 at BMO Capital

BMO Capital analyst Gary Nachman raised his price target for Sage Therapeutics to $203 saying this morning's "very strong" Phase II major depressive disorder data "transforms the company." The analyst sees SAGE-217 as a likely game-changer for the "very large markets" of major depressive disorder and postpartum depression. He reiterates an Outperform rating on Sage Therapeutics.

  • 07

    Dec

SAGE Sage Therapeutics
$91.90

2.11 (2.35%)

12/07/17
LEER
12/07/17
NO CHANGE
Target $246
LEER
Outperform
Sage Therapeutics price target raised to $246 from $123 at Leerink
12/07/17
RBCM
12/07/17
NO CHANGE
Target $280
RBCM
Outperform
Sage Therapeutics price target raised to $280 from $137 at RBC Capital
12/07/17
RBCM
12/07/17
NO CHANGE
Target $280
RBCM
Top Pick
RBC puts Street-high price target of $280 on Sage Therapeutics
RBC Capital analyst Brian Abrahams raised his price target for Sage Therapeutics to $280 from $137 after the company reported Phase II trial results for SAGE-217 in major depressive disorder. The target represents the high among Wall Street sell-side analysts, according to Bloomberg. The "outstanding" data show a "differentiated profile that could be game-changing" if replicated in Phase III, and may lead to $3.8B in out-year sales, Abrahams tells investors in a research note. The analyst still sees "considerable fundamental upside" in shares despite today's rally. He also sees a "good likelihood" of takeout at a valuation premium to current levels. Abrahams keeps an Outperform rating on Sage Therapeutics. The stock in midday trading is up 78%, or $72.10, to $164.00.
12/07/17
CHDN
12/07/17
NO CHANGE
Target $225
CHDN
Buy
Sage Therapeutics price target raised to $225 from $140 at Chardan
Chardan analyst Gbola Amusa raised his price target for Sage Therapeutics to $225 cting the positive top-line results from the Phase II trial of SAGE-217 in moderate-to-severe major depressive disorder. Importantly, the beneficial effects of SAGE-217 were reported as soon as the morning following the first dose, the analyst tells investors in a research note. He believes this further demonstrates the "rapid effect" of SAGE-217 compared to standard treatments for major depressive disorder. He sees the data as a "step in the direction of blockbuster sales" and keeps a Buy rating on Sage.

TODAY'S FREE FLY STORIES

SAGE

Sage Therapeutics

$158.03

-6.62 (-4.02%)

17:25
12/14/17
12/14
17:25
12/14/17
17:25
Conference/Events
Sage Therapeutics management to meet with RBC Capital »

Dinner Meeting will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

ORCL

Oracle

$50.20

0.14 (0.28%)

17:24
12/14/17
12/14
17:24
12/14/17
17:24
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle CEO Hurd says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ADBE

Adobe

$175.00

-1.83 (-1.03%)

17:23
12/14/17
12/14
17:23
12/14/17
17:23
Hot Stocks
Adobe targeting subscription bookings growth of 20% in FY18 »

Says expect quarterly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ADBE

Adobe

$175.00

-1.83 (-1.03%)

17:20
12/14/17
12/14
17:20
12/14/17
17:20
Hot Stocks
Adobe says advertising cloud had a 'strong' year »

Says advertising cloud…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ORCL

Oracle

$50.19

0.14 (0.28%)

17:20
12/14/17
12/14
17:20
12/14/17
17:20
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle says currency…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ORCL

Oracle

$50.19

0.14 (0.28%)

17:19
12/14/17
12/14
17:19
12/14/17
17:19
Earnings
Oracle sees Q3 adjusted EPS 68c-70c, consensus 72c »

Sees Q3 revenue growth of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

UBA

Urstadt Biddle

$22.71

-0.48 (-2.07%)

, UBP

Urstadt Biddle Properties Inc.

$18.00

-0.01 (-0.06%)

17:17
12/14/17
12/14
17:17
12/14/17
17:17
Hot Stocks
Urstadt Biddle raises quarterly dividend by 0.5c to 27c »

At their regular meeting…

UBA

Urstadt Biddle

$22.71

-0.48 (-2.07%)

UBP

Urstadt Biddle Properties Inc.

$18.00

-0.01 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$50.19

0.14 (0.28%)

17:14
12/14/17
12/14
17:14
12/14/17
17:14
Hot Stocks
Oracle says customer adoption of cloud products 'remains very strong' »

Says expects to continue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

NQ

NQ Mobile

$4.13

0.02 (0.49%)

17:14
12/14/17
12/14
17:14
12/14/17
17:14
Hot Stocks
NQ Mobile announces partnership with Chery Automotive »

NQ Mobile Inc announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

CVX

Chevron

$119.53

-0.4 (-0.33%)

, SLB

Schlumberger

$62.37

-0.93 (-1.47%)

17:12
12/14/17
12/14
17:12
12/14/17
17:12
Periodicals
Chevron near pact with Schlumberger to drill six Brazil wells, Reuters says »

Chevron (CVX) has reached…

CVX

Chevron

$119.53

-0.4 (-0.33%)

SLB

Schlumberger

$62.37

-0.93 (-1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

VSTM

Verastem

$3.65

-0.15 (-3.95%)

17:07
12/14/17
12/14
17:07
12/14/17
17:07
Syndicate
Verastem files to sell $25M of common stock »

BTIG is acting as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNR

Denbury Resources

$1.62

0.02 (1.25%)

17:06
12/14/17
12/14
17:06
12/14/17
17:06
Syndicate
Breaking Syndicate news story on Denbury Resources »

Denbury Resources files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCBS

Nicolet Bankshares

$56.52

-1.12 (-1.94%)

17:05
12/14/17
12/14
17:05
12/14/17
17:05
Initiation
Nicolet Bankshares initiated  »

Nicolet Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GALE

Galena

$0.32

0.0399 (14.24%)

17:05
12/14/17
12/14
17:05
12/14/17
17:05
Hot Stocks
Galena to adjourn special meeting until Friday, December 29 »

Galena Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDS

FactSet

$202.46

0.44 (0.22%)

17:04
12/14/17
12/14
17:04
12/14/17
17:04
Initiation
FactSet initiated  »

FactSet initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

UTX

United Technologies

$123.76

-0.54 (-0.43%)

17:04
12/14/17
12/14
17:04
12/14/17
17:04
Hot Stocks
United Technologies awarded $6.7B U.S. Air Force contract »

United Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNPR

Juniper

$28.80

-0.31 (-1.06%)

17:03
12/14/17
12/14
17:03
12/14/17
17:03
Initiation
Juniper initiated  »

Juniper resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$37.90

-0.25 (-0.66%)

17:03
12/14/17
12/14
17:03
12/14/17
17:03
Initiation
Cisco initiated  »

Cisco resumed with a Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

ANET

Arista Networks

$226.72

1.59 (0.71%)

17:02
12/14/17
12/14
17:02
12/14/17
17:02
Initiation
Arista Networks initiated  »

Arista Networks resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

GRA

W.R. Grace

$69.98

-0.46 (-0.65%)

, ALB

Albemarle

$127.58

-2.2 (-1.70%)

17:01
12/14/17
12/14
17:01
12/14/17
17:01
Hot Stocks
W.R. Grace to acquire Polyolefin Catalysts unit of Albemarle for $416M »

W.R. Grace (GRA) signed…

GRA

W.R. Grace

$69.98

-0.46 (-0.65%)

ALB

Albemarle

$127.58

-2.2 (-1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

LENS

Presbia

$1.93

-0.25 (-11.47%)

16:59
12/14/17
12/14
16:59
12/14/17
16:59
Hot Stocks
Presbia executive chairman resigns as company reorders operational priorities »

Presbia announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HES

Hess Corp.

$42.67

-1.43 (-3.24%)

16:58
12/14/17
12/14
16:58
12/14/17
16:58
Periodicals
Elliot seeks ouster of Hess Corp. CEO, or sale of company, WSJ reports »

Elliott Management is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDR

DDR Corp.

$7.96

-0.11 (-1.36%)

16:52
12/14/17
12/14
16:52
12/14/17
16:52
Hot Stocks
Breaking Hot Stocks news story on DDR Corp. »

DDR Corp up 8.7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDXC

ChromaDex

$6.24

-0.3 (-4.59%)

16:52
12/14/17
12/14
16:52
12/14/17
16:52
Syndicate
Breaking Syndicate news story on ChromaDex »

ChromaDex files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HES

Hess Corp.

$42.67

-1.43 (-3.24%)

16:51
12/14/17
12/14
16:51
12/14/17
16:51
Hot Stocks
Hess Corp. up 6.5% after DJ reports Elliot seeks to replace CEO »

In after-hours trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.